About Rituximab
            
            Class: | Monoclonal antibody (anti-CD20)  
Use: | Treatment of certain types of non-Hodgkin lymphoma, chronic lymphocytic leukemia (CLL), and rheumatoid arthritis in combination with methotrexate.  
Adult dose: | Initial dose of 375 mg/m² IV on day 1, followed by 500 mg/m² IV on day 8 for lymphoma; for CLL, 375 mg/m² IV on day 1 of the first cycle, then 500 mg/m² IV on day 1 of subsequent cycles. For rheumatoid arthritis, 1000 mg IV on days 1 and 15, then every 24 weeks.  
Pediatric dose: | Not 
         
        
            
                
                
                    
                        Drug Class
                    
                    Monoclonal antibody (anti-CD20)
                 
                
                
                    
                        Uses & Indications
                    
                    Treatment of certain types of non-Hodgkin lymphoma, chronic lymphocytic leukemia (CLL), and rheumatoid arthritis in combination with methotrexate.
                 
                
                
                    
                        Storage Requirements
                    
                    Store in the refrigerator at 2°C to 8°C (36°F to 46°F). Do not freeze. Protect from light.
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: PFIZER EUROPE MA EEIG, BELGIUM
                    
                    
                    Package Size
                    1 Glass Vial (10 ml)
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 922.00
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        Initial dose of 375 mg/m² IV on day 1, followed by 500 mg/m² IV on day 8 for lymphoma; for CLL, 375 mg/m² IV on day 1 of the first cycle, then 500 mg/m² IV on day 1 of subsequent cycles. For rheumatoid arthritis, 1000 mg IV on days 1 and 15, then every 24 weeks.
                    
                    
                        Pediatric Dose
                    
                    
                        Not established for pediatric use; safety and efficacy have not been determined in children.
                    
                 
                
                
                    
                        Side Effects
                    
                    Infusion-related reactions, infections, neutropenia, thrombocytopenia, anemia, fatigue, nausea, and rash.
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Known hypersensitivity to rituximab or any component of the formulation; active severe infections; and history of progressive multifocal leukoencephalopathy (PML).
         
        
        
            
                Important Warnings
            
            Risk of severe infusion reactions, infections (including PML), and tumor lysis syndrome. Monitor for signs of infection and infusion-related reactions. Pre-medication with antihistamines and acetaminophen is recommended.
         
        
        
        
        
        
        
        
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.